chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was here for nurse visit for COVID vaccine. Administered Moderna COVID 19 vaccine in left deltoid at 09:30. No immediate reaction noted. At 09:47 patient stated that her left arm was tingling, and she was feeling hot. Patient states she feels like it's an anxiety attack and she has anxiety about shots. Patient became nauseous and shaky. Physician was notified. O2 97% P 76 T98. 0 09:53 received verbal ok by Dr to administer BENADRYL 25mg to patient, administered Diphenhydramine 25mg 1 PO without difficulty. I applied a cool compress to back of neck.  10AM patient stated she felt better. 10:02 she stated the tingling in her arm was gone. Patient did vomit at 10:06. She stated she felt much better. Patient stayed in office until 10:15 she stated she felt better. Per Dr patient is ok to return for 2nd dose of COVID vaccine. Let patient know that if she developed any other symptoms to call us or if she has difficulty breathing or severe chest pain she needs to go to ER. Patient stated understanding.
Patient was diagnosed with shingles after 2 weeks of vaccination and is improving. No history of shingles in past or other adverse reaction associated with vaccines earlier. Shingles affected part of her face around eyes but no ocular involvement. No other symptoms.  Follow-up information received - RE: Missing information letter dated 1/21/2010. Unfortunately, this information is not available to us. When a report of symptoms suggesting a possible adverse event of interest is received, our team attempts to contact the reporting individual - provided that permission to contact has been granted. We have contacted this patient and he or she has agreed to share his or her contact information with VAERS.  Pt. e-mail provided - Phone number not available.
Within 24hr of vaccine patient began having episodes of turning head to right, eyes rolling back and "zoning out." Lasts 1-2 sec and patient recovers. Happening 2-3 times a day since. No previous problems.
left arm blew up; COVID arm; it was hard to the touch; painful to the touch; had a big red spot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left arm blew up), VACCINATION SITE INDURATION (it was hard to the touch), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PAIN (painful to the touch) and VACCINATION SITE RASH (had a big red spot) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PERIPHERAL SWELLING (left arm blew up), VACCINATION SITE INDURATION (it was hard to the touch), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PAIN (painful to the touch) and VACCINATION SITE RASH (had a big red spot). On 27-Jan-2021, PERIPHERAL SWELLING (left arm blew up), VACCINATION SITE INDURATION (it was hard to the touch), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PAIN (painful to the touch) and VACCINATION SITE RASH (had a big red spot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD21-023517 (Patient Link).
Drainage, low grade fever, cough and ultimately body aches but they didn't come the next day. I also had a headache at the beginning. Symptoms stayed around for about a week. The cough is not a issue anymore. The doctor did prescribe molnupiravir. I'll finish the prescription tonight 4/19/2022.
A report has been received from a Health Professional concerning a 3 years 6 days old, female patient, who had been receiving Nasal FLUMIST QUADRIVALENT 0.2 Millilitres. FLUMIST QUADRIVALENT started on 19-Jan-2016. Nurse reported that the patient was administered FLUMIST which was expired on 04-Jan-2016. FLUMIST QUADRIVALENT was discontinued on 19-Jan-2016. The outcome of the event of expired dose was unknown. The report was considered to be non-serious.
pts daughter stated on 17NOV92 pt devel edema & redness @ inject site of Pneumococcal vax, generalized aching & sore throat; sx improved over several day w/symptomatic treatment;
Dose 1 no problem at all, a little fatigue Dose 2 received the shot at 0800, at 0200 on 1-27-21 woke to use restroom, right side of my body I could not feel and fell into the hallway wall.  I immediately became dizzy and screamed for my husband thinking I was having a stroke as I could not walk well.  The dizzy/numbness lasted until  1-28-2021.  I did call my employee health to mention my symptoms so it could be documented.  On 10-8-2021 I went to my employee health for my first booster shot and was denied.  I was told to call my doctor and get a note in order to received the booster shot.  My physician was notified, and I was told not to receive the booster shot safely.  I was given the option to have a referral to see an allergist.
Noticed blotchy rash on tops of both feet on Monday evening 4 days after vaccine was administered Noticed blotchy rash on lower right and left legs on Tuesday evening 5 days after vaccine was administered.  Not itchy or painful.
Patient seen in the office today.  She reported having COVID 19 booster on 1/21/22.  On 01/23/22 she is having episodes of rapid heart rate that last a few minutes to more than an hour.  These episodes make her anxious.  She is also complaining of generalized muscle aches.
Patient was given ZOSTAVAX immunization on 7/29/12. Patient was diagnosed with Guillain-Barre on 8/22/12. Patient was treated at hospital and diagnosed there, then patient went to Rehab hospital for 10 days.
Peripheral neuropathy tingling  in left foot the evening of when vaccine received, lasted about a minute. After mild numbness, most noticed when changed from sitting/lying to standing position.
Joint pain bilateral hips and r leg, l tingling and numb around ankle, left thumb swollen, low grade fever 103.00
Redness in back of arm (PNEUMOVAX). Packed it and TYLENOL.
Fever of 100.5, chills, body aches. Symptoms lasted until next morning.
back pain; neck pain; temporary fever (24 hours); chills (48 hours); This spontaneous case was reported by a non-health professional and describes the occurrence of   in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
I received my first dose of Pfizer on 9/5/2021. Within about 10 minutes, my left hand became tingly and had a pins-and-needles feeling that rapidly traveled throughout the left side of my body, including my face, neck, arm, shoulder, torso, hip, leg, and foot. The left side of my body quickly became numb and within 45 minutes. There was zero sensation on the left side of my body. I then went home afterwards. I don't remember much about that night, as I fell asleep shortly after getting home, which is highly unusual for me. The next day, I felt okay, though I still had pins and needles on the left side of my face and above my lip. I then had fatigue, body aches, and low-grade fever on 9/7/2021 and 9/8/2021. I have continued to have tingling on the left side of my face, from my cheekbone to my upper lip. It waxes and wanes. Also, my menstrual cycle ended on 9/3/2021, which was 2 days before the injection. However, on 9/6/2021, I experienced what felt like severe menstrual cramps and a pinkish vaginal discharge, which lasted two days.
Pt recvd 2nd dose of vax on 2SEP92; approx 1/2 hr  p/vax pt exp blurred vision & visual floaters, dizziness, pallor, photosensitivity, h/a, nausea, tinnitis; treated w/DPH;
Red raised hives surround by red skin.  When hives are pressed they turn white.  Hives started on his bottom and then were next observed on his right leg and left arm.  They can then appear large with a red irregular ringed circle.  They range in size from 3 mm to 80 mm.  He had a previous hive reaction, but the vaccine was not known at the time.
My wife has small bumps all over her body; Injection site is crusty; Hives are itchy,flaky, itch so bad; Needle during administration cause a lot of blood to come out; Hives are itchy,flaky, itch so bad; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (My wife has small bumps all over her body), VACCINATION SITE REACTION (Injection site is crusty), URTICARIA (Hives are itchy,flaky, itch so bad), VACCINATION SITE HAEMORRHAGE (Needle during administration cause a lot of blood to come out) and RASH PRURITIC (Hives are itchy,flaky, itch so bad) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939905, 025C21A and 028A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and LEVOTHYROXINE for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (My wife has small bumps all over her body), VACCINATION SITE REACTION (Injection site is crusty), URTICARIA (Hives are itchy,flaky, itch so bad), VACCINATION SITE HAEMORRHAGE (Needle during administration cause a lot of blood to come out) and RASH PRURITIC (Hives are itchy,flaky, itch so bad). At the time of the report, RASH MACULAR (My wife has small bumps all over her body), VACCINATION SITE REACTION (Injection site is crusty), URTICARIA (Hives are itchy,flaky, itch so bad), VACCINATION SITE HAEMORRHAGE (Needle during administration cause a lot of blood to come out) and RASH PRURITIC (Hives are itchy,flaky, itch so bad) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.
excessive sleeping (x @ least 18hrs) w/episode of emesis & pallor following the vomiting;not floppy or unresponsive, but diff to arouse;resolved by next day
patient received the vaccination and within a few minutes she developed sore throat, wheezing; patient received the vaccination and within a few minutes she developed sore throat, wheezing; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 18Dec2020 at 08:30 at single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On 18Dec2020 at 08:30, the patient experienced sore throat and wheezing; within a few minutes she developed sore throat, wheezing. Facility where the COVID-19 vaccine was administered was workplace clinic. The adverse events resulted in Emergency room/department visit or urgent care. The patient received "RT" treatments. It was unknown if prior to vaccination the patient was diagnosed with COVID-19 and it was unknown if she was tested for COVID-19 since the vaccination. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
They called it hives; They were very itchy/everything was still itchy; small chicken pox type eruptions started on her neck, spread down to her trunk, then all the way down to the knee; the injection site hurt a little/still had injection site pain.; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (They called it hives), PRURITUS (They were very itchy/everything was still itchy), RASH (small chicken pox type eruptions started on her neck, spread down to her trunk, then all the way down to the knee) and VACCINATION SITE PAIN (the injection site hurt a little/still had injection site pain.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included Cancer (NOS) (history of cancer twice but only received chemo once).Concurrent medical conditions included mixed connective tissue disease (autoimmune disease).On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (They called it hives), PRURITUS (They were very itchy/everything was still itchy), RASH (small chicken pox type eruptions started on her neck, spread down to her trunk, then all the way down to the knee) and VACCINATION SITE PAIN (the injection site hurt a little/still had injection site pain.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (They called it hives), PRURITUS (They were very itchy/everything was still itchy) and RASH (small chicken pox type eruptions started on her neck, spread down to her trunk, then all the way down to the knee) had resolved and VACCINATION SITE PAIN (the injection site hurt a little/still had injection site pain.) had not resolved. Concomitant medications were not provided. It was reported that after the second dose the injection site hurt a little, then 5 days later small chicken pox type eruptions started on her neck, spread down to her trunk, then all the way down to the knee. They were very itchy and mostly toward the center of her body. She took Benadryl, everything was still itchy, so she went to the emergency room. They called it hives, gave her a steroid, Pepcid and Benadryl and within 3 hours the itching went away and within 5 or 6 hours everything went away, although still had injection site pain. This case was linked to MOD-2021-338296 (Patient Link).
This spontaneous report was received from a physician via company representative refers to a 73 year old female patient. The medical history, concurrent conditions were unknown. On 10-OCT-2016, the patient was vaccinated with ZOSTAVAX lot # M026874, 19-JUL-2017, 0.65 ml. Concomitant therapies included TYLENOL, unspecified thyroid medication and other unspecified medications. On 11-OCT-2016, the patient had a small injection site, determined to be rash after receiving ZOSTAVAX that became widespread on the patient's body. It was unknown if patient put something on the rash for treatment that made the rash spiral out of control. No treatment was rendered for the event. The outcome of the event was reported as not recovered/not resolved. The patient sought medical attention (spoke with physician). Additional information has been requested.
Pfizer-BioNTech COVID- 19 Vaccine EUA: During post observation period, vaccine recipient had a syncopal episode and were monitored by EMS.
Information has been received from a nurse, referring to a multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with an improperly stored doses of GARDASIL 9 lot # M037770, expiration date on 01-JUN-2019 (strength, dose, anatomical location and administration route were not provided) for prophylaxis. No adverse effects were reported. The vaccines had one temperature excursion of 31 Fahrenheit (F) during a time frame of 336 hours; it was confirmed that all the vaccines were administered, no previous excursions occurred and no digital data logger was involved. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1705USA009727.
This spontaneous report was received from a female patient of unknown age, reporting on herself. Information regarding the patient's medical history, concurrent conditions or concomitant therapy was not provided. On September 2014, the patient was vaccinated with ZOSTAVAX Subcutaneous injection (strength, dose, lot number and expiration date were not provided). Subsequently, after the vaccination, the patient experienced red patches of skin all over her legs. At the time of reporting, she had dark scars from where the red patches were. The patient reported that she had a large biopsy taken out of her leg (results not provided) and her physician confirmed that her red patches were a reaction to the ZOSTAVAX vaccine. The patient tried to use creams for her scars but it resulted in her legs having dark blotches everywhere. No product quality complaints were reported. At the time of this report, the outcome of hypersensitivity, rash maculo-papular and scar was unknown. It was considered that hypersensitivity was related to ZOSTAVAX. Additional information has been requested.
INJECTION SITE REDNESS, PAIN. BODY ACHES,CHILLS. Fever, headache, decreased appetite.
hard around injection site; Injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (hard around injection site) and INJECTION SITE PAIN (Injection site soreness) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised. Concomitant products included INSULIN LISPRO (HUMALOG), INSULIN DEGLUDEC (TRESIBA) and ANAKINRA (KINERET) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced INJECTION SITE MASS (hard around injection site) and INJECTION SITE PAIN (Injection site soreness). At the time of the report, INJECTION SITE MASS (hard around injection site) and INJECTION SITE PAIN (Injection site soreness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: increased (High) elevated body temperature.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was provided as advil
Patient noted red, raised rash on back of thigh on 5/21/08.  Went to work.  Nurses at work noted area to be 10 cm and was on back of both thighs.  Complained of itchy sensation both thighs and throat and her ears felt "funny."  Prior to going to work that AM took third dose of oral TYPHOID.  Seen by doctor.  Placed on Medrol dose pack.
This spontaneous report was received from a Physician and refers to unspecified patients of unknown age and gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On unspecified dates since September 2016, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # M036156 with expiry date 23-FEB-2019) (dose, route and anatomical location not reported) for prophylaxis. Exact time frame and temperature at which the vaccine underwent excursion was unknown. However it was reported that the lot # M036156 underwent a temperature excursion of 32 degrees Fahrenheit to 35 degrees Fahrenheit for a cumulative time frame of 2 hours on 13-MAR-2017 and 27-MAR-2017. Maximum individual time frame was reported as 1 hour. There was no previous temperature excursion. The call was not because of data logger. No adverse effect were reported. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA005462: US-009507513-1705USA005438: US-009507513-1705USA005436: US-009507513-1705USA005439: US-009507513-1705USA005437: US-009507513-1704USA014447: US-009507513-1705USA005435:
Fever 101-102 Headache Aches and pains Brain fog Insomnia  Sore arm
Itching all over, wheezing, dizziness, hoarse, pale, weak, irregular heart rate increased, metallic taste in mouth. Driven to PCP's office by a relative pt received IM Benadryl & Steroids. Given RX for PO Benadryl, Solu-Medrol and Zantac. Has completed meds. Irregular HR & metallic taste persisting. Plans to f/u with cardiologist.
Full body flushing, mild tingling on face, mild hives on neck Duration ~12 hours 50mg Benadryl at onset 25mg Benadryl at 4 and 8 hours after onset 650mg Tylenol at 4 and 8 hours after onset
As of disease investigation on 8/24/21 case reported symptom onset of 8/7/21 which included fever, subjective fever, chills, runny nose, sore throat, new olfactory disorders, fatigue, cough and congestion with symptoms resoloving 8/10/21
Oct. 24, 2014 patient received vaccines. Oct. 25, 2014 he had fever as high as 103.8 (axillary) temp. Gave him TYLENOL, cool towels, liquids but could not get fever to go down. Whenever he went to sleep he began jerking/jumping (febrile seizures). He then started having diarrhea. Oct. 26, 2014 I called the on call nurse for advice and gave him MOTRIN and fever began to decrease some. Oct 27 I took him back to pediatrician.
Hard and had a bruise at the injection site; Hard and had a bruise at the injection site; Arm hurt; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Apr-2021. The most recent information was received on 02-Aug-2021 and was forwarded to Moderna on 02-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Hard and had a bruise at the injection site), VACCINATION SITE INDURATION (Hard and had a bruise at the injection site) and VACCINATION SITE PAIN (Arm hurt) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (Hard and had a bruise at the injection site), VACCINATION SITE INDURATION (Hard and had a bruise at the injection site) and VACCINATION SITE PAIN (Arm hurt). At the time of the report, VACCINATION SITE BRUISING (Hard and had a bruise at the injection site), VACCINATION SITE INDURATION (Hard and had a bruise at the injection site) and VACCINATION SITE PAIN (Arm hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up information received included outcome of the events.
Patient Aged 5-11 was given and adult dose of the Pfizer COVID-19 12 year+ vaccine. Doctor informed mother of vaccination with the adult version of the COVID-19 vaccine. Mom stated patient currently afebrile,active and playful.